Description 

Noninvasive ventilation (NIV) benefits have become increasingly recognized, in particular, NIV has proven effective for hypercapnic respiratory failure. High-flow nasal cannula (HFNO) has shown promise in treating hypoxic respiratory failure. This presentation will discuss how HFNO with NIV enables a complementary approach for weaning efficiency. In light of the current pandemic, this presentation will also discuss the use of HFNC and NIV therapy in COVID-19 patients. Following the lecture with be an interactive panel discussion with three experts in HFNO and NIV therapies.

 

Learning Objectives:

Upon completion of this activity, the participant will be able to:

1. Discuss indications for NIV and HFNO

2. Discuss the use of HFNO and NIV therapy in COVID-19 patients

3. Demonstrate how HFNO and NIV can work in complementary fashion